Brolucizumab

Brolucizumab is a medication used to treat certain eye conditions, like wet age-related macular degeneration, which can cause vision loss. It works by blocking a protein called vascular endothelial growth factor (VEGF), responsible for abnormal blood vessel growth and fluid leakage in the eye. By inhibiting VEGF, Brolucizumab helps reduce swelling and prevent further damage to the retina, supporting clearer vision. It is typically administered through injections into the eye at regular intervals under the supervision of an eye specialist.